New England Journal of Medicine Publishes Results from Phase 2 Study of AKCEA-APO(a)-LRx in Patients with Lp(a)-driven Cardiovascular Disease
In: Legal Monitor Worldwide, 2020-01-03
Zeitungsartikel
Zugriff:
(GlobeNewswire) - Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), announced that results from a Phase 2 study evaluating AKCEA-APO(a)-LRx, [...]
Titel: |
New England Journal of Medicine Publishes Results from Phase 2 Study of AKCEA-APO(a)-LRx in Patients with Lp(a)-driven Cardiovascular Disease
|
---|---|
Zeitschrift: | Legal Monitor Worldwide, 2020-01-03 |
Veröffentlichung: | 2020 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|